The common indication among all GLP-1 drugs is type 2 diabetes: they are prescribed for patients whose hemoglobin A1C is greater than 8.5%, who have a need for weight loss and who have a need to avoid hypoglycemia
It does not evaluate providers or predict drug response
But headline percentages only tell part of the story, because the two tablets are taken in very different ways, and in everyday life, how easy a medicine is to take often matters as much as its trial numbers
In clinical trials, tirzepatide has resulted in larger amounts of weight loss than semaglutide
These experts not only provide advice but also teach the correct injection techniques
Significant weight loss isnt always a benefit for older adults, especially if it means the loss of bone and muscle mass, which are critical for good physical health